Deaths from severe heart attacks following admission to hospital have nearly halved in six years as a result of advances in medical treatment. In the largest study of its kind, research led by the University of Edinburgh, analyzed hospital treatment and outcomes for 44,372 patients admitted to 113 hospitals in 14 countries with heart attacks or unstable angina (threatened heart attacks).
Deaths from severe heart attacks following admission to hospital have nearly halved in six years as a result of advances in medical treatment, revealed by Edinburgh researchers.
INTERMACS, the Interagency Registry for Mechanically Assisted Circulatory Support, and its role in facilitating ongoing development of ventricular assistive devices (VAD) will be the subject of presentations and discussion during the International Society for Heart and Lung Transplantation (ISHLT) 27th Annual Meeting and Scientific Sessions this week.
Proper formation of the proteins that power heart and skeletal muscle seems to rely on a precise concentration of a “chaperone” protein known as UNC-45, according to a new study.
The anti-anginal medication ranolazine was shown to be safe in regard to certain outcomes but did not reduce the risk of major cardiovascular events such as death, heart attack or recurrent ischemia following acute coronary syndromes, according to a study in the April 25 issue of JAMA.
Join patients and staff members from the Program in Heart Failure and Transplantation for the second annual ?And the Beat Goes On? fundraiser May 18 at the Burgundy Basin Inn, 1361 Marsh Road, Pittsford.
Researchers from Canada and Australia have found that the use of remote monitoring for patients with chronic heart failure has the potential to significantly improve clinical outcomes (mortality, morbidity and quality indicators).
Individuals with some forms of heart failure are treated with drugs that are known as beta-blockers because they target proteins known as beta-adrenergic receptors (beta-ARs).
Encouraging patients to become involved in providing their own care can reduce the cost and improve the quality of long-term medical treatment, say researchers from Massachusetts General Hospital and Massachusetts Institute of Technology in PLoS Medicine this week.
Monitoring patients’ health by phone can make a real difference to people with chronic heart failure, according to a study published on bmj.com.